3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
24
Melanoma
21
Carcinoma, Renal Cell
21
Squamous Cell Carcinoma of Head and Neck
8
Neoplasms
8
Lung Neoplasms
8
Colorectal Neoplasms
8
Prostatic Neoplasms
7
Neoplasm Metastasis
7
Stomach Neoplasms
6
Carcinoma, Transitional Cell
6
Carcinoma, Hepatocellular
6
Adenocarcinoma Of Esophagus
6
Rectal Neoplasms
5
Hodgkin Disease
5
Triple Negative Breast Neoplasms
4
Ovarian Neoplasms
4
Nasopharyngeal Carcinoma
4
Endometrial Neoplasms
4
Uterine Cervical Neoplasms
3
Urinary Bladder Neoplasms
3
Thyroid Neoplasms
3
Pancreatic Neoplasms
3
Oropharyngeal Neoplasms
3
Multiple Myeloma
3
Leukemia, Myeloid, Acute
3
Glioblastoma
3
Esophageal Neoplasms
3
Colonic Neoplasms
3
Brain Neoplasms
3
Interventions
X-Rays
5
Phantoms, Imaging
5
Nuclear Medicine Department, Hospital
5
Magnetic Resonance Spectroscopy
5
Specimen Handling
4
Biopsy
4
ulixertinib
2
tipifarnib
2
selpercatinib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
tazemetostat
1
talazoparib
1
palbociclib
1
olaparib
1
irinotecan sucrosofate
1
Vemurafenib
1
Temozolomide
1
Pharmacogenomic Variants
1
LY3023414
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroectodermal Tumors, Primitive, Peripheral
×
Nivolumab
×
30 days
×
Clear all
No trials found.